全文获取类型
收费全文 | 2575篇 |
免费 | 174篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 63篇 |
妇产科学 | 67篇 |
基础医学 | 267篇 |
口腔科学 | 176篇 |
临床医学 | 270篇 |
内科学 | 485篇 |
皮肤病学 | 83篇 |
神经病学 | 198篇 |
特种医学 | 45篇 |
外科学 | 319篇 |
综合类 | 69篇 |
一般理论 | 4篇 |
预防医学 | 235篇 |
眼科学 | 131篇 |
药学 | 175篇 |
中国医学 | 12篇 |
肿瘤学 | 147篇 |
出版年
2023年 | 30篇 |
2022年 | 58篇 |
2021年 | 118篇 |
2020年 | 77篇 |
2019年 | 116篇 |
2018年 | 85篇 |
2017年 | 70篇 |
2016年 | 80篇 |
2015年 | 88篇 |
2014年 | 102篇 |
2013年 | 145篇 |
2012年 | 183篇 |
2011年 | 173篇 |
2010年 | 101篇 |
2009年 | 81篇 |
2008年 | 126篇 |
2007年 | 144篇 |
2006年 | 111篇 |
2005年 | 113篇 |
2004年 | 99篇 |
2003年 | 96篇 |
2002年 | 52篇 |
2001年 | 34篇 |
2000年 | 44篇 |
1999年 | 35篇 |
1998年 | 15篇 |
1997年 | 18篇 |
1995年 | 8篇 |
1992年 | 22篇 |
1991年 | 28篇 |
1990年 | 22篇 |
1989年 | 35篇 |
1988年 | 21篇 |
1987年 | 17篇 |
1986年 | 14篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1981年 | 8篇 |
1979年 | 13篇 |
1977年 | 6篇 |
1975年 | 7篇 |
1974年 | 10篇 |
1973年 | 7篇 |
1972年 | 9篇 |
1971年 | 12篇 |
1969年 | 16篇 |
1968年 | 8篇 |
1967年 | 7篇 |
1966年 | 7篇 |
排序方式: 共有2759条查询结果,搜索用时 14 毫秒
61.
62.
63.
Krystyna M. Wozniak Ying Wu Mohamed H. Farah Bruce A. Littlefield Kenichi Nomoto Barbara S. Slusher 《Neurotoxicity research》2013,24(3):338-344
Eribulin mesylate (E7389, INN:eribulin mesilate Halaven®) is a non-taxane microtubule dynamics inhibitor currently in clinical use for advanced breast cancer. Other microtubule-targeting agents for breast cancer, including paclitaxel and ixabepilone, display a common treatment dose-limiting toxicity of peripheral neuropathy (PN). In an earlier study, we found eribulin mesylate had a lower propensity to induce PN in mice than either paclitaxel or ixabepilone. In the current study, we compared additional PN induced by paclitaxel versus eribulin mesylate when administered to mice with preexisting paclitaxel-induced PN. Initially, paclitaxel at 0.75 × its maximum tolerated dose (MTD; 22.5 mg/kg) was given on a Q2Dx3 regimen for 2 weeks. The second chemotherapy was 0.5 MTD eribulin mesylate (0.875 mg/kg) or paclitaxel (15 mg/kg) on a similar regimen, starting 2 weeks after the first. Initial paclitaxel treatment produced significant decreases in caudal nerve conduction velocity (NCV; averaging 19.5 ± 1 and 22.2 ± 1.3 %, p < 0.001) and amplitude (averaging 53.2 ± 2.6 and 72.4 ± 2.1 %, p < 0.001) versus vehicle when measured 24 h or 2 weeks after dosing cessation, respectively. Additional 0.5 MTD paclitaxel further reduced caudal NCV and amplitude relative to immediately before initiation of the second regimen (by 11 ± 2.1 and 59.2 ± 5 %, p < 0.01, respectively). In contrast, 0.5 MTD eribulin mesylate caused no further decrease in caudal NCV. In conclusion, unlike additional paclitaxel treatment, eribulin mesylate administered to mice with preexisting paclitaxel-induced PN had limited additional deleterious effects at 6 weeks. These preclinical data suggest that eribulin mesylate may have reduced tendency to exacerbate preexisting paclitaxel-induced PN in clinical settings. 相似文献
64.
65.
Emilio A. Herrera René Alegría Marcelo Farias Farah Díaz‐López Cherie Hernández Ricardo Uauy Timothy R. H. Regnault Paola Casanello Bernardo J. Krause 《The Journal of physiology》2016,594(6):1553-1561
Key points
- Intrauterine growth restriction (IUGR) is associated with short‐ and long‐term detrimental cardiometabolic effects.
- Mice and rats are commonly used to assess IUGR, but differences in placental and fetal developmental physiology relative to those in humans highlight the need for alternative small animal IUGR models.
- We developed a guinea pig IUGR model by gradual occlusion of uterine arteries by ameroid constrictor implantation. In this model, reduced uterine blood flow was associated with IUGR, allowing in vivo assessment of fetal growth trajectory and umbilico‐placental vascular function in conscious animals.
- The intervention induces placental vascular dysfunction and remodelling, as well as altered fetal abdominal growth resulting in an asymmetric IUGR and preserved brain growth.
Abstract
Intra‐uterine growth restriction (IUGR) is associated with short and long‐term metabolic and cardiovascular alterations. Mice and rats have been extensively used to study the effects of IUGR, but there are notable differences in fetal and placental physiology relative to those of humans that argue for alternative animal models. This study proposes that gradual occlusion of uterine arteries from mid‐gestation in pregnant guinea pigs produces a novel model to better assess human IUGR. Fetal biometry and in vivo placental vascular function were followed by sonography and Doppler of control pregnant guinea pigs and sows submitted to surgical placement of ameroid constrictors in both uterine arteries (IUGR) at mid‐gestation (35 days). The ameroid constrictors induced a reduction in the fetal abdominal circumference growth rate (0.205 cm day−1) compared to control (0.241 cm day−1, P < 0.001) without affecting biparietal diameter growth. Umbilical artery pulsatility and resistance indexes at 10 and 20 days after surgery were significantly higher in IUGR animals than controls (P < 0.01). These effects were associated with a decrease in the relative luminal area of placental chorionic arteries (21.3 ± 2.2% vs. 33.2 ± 2.7%, P < 0.01) in IUGR sows at near term. Uterine artery intervention reduced fetal (∼30%), placental (∼20%) and liver (∼50%) weights (P < 0.05), with an increased brain to liver ratio (P < 0.001) relative to the control group. These data demonstrate that the ameroid constrictor implantations in uterine arteries in pregnant guinea pigs lead to placental vascular dysfunction and altered fetal growth that induces asymmetric IUGR. 相似文献66.
Improved surgical margin definition by narrow band imaging for resection of oral squamous cell carcinoma: A prospective gene expression profiling study 下载免费PDF全文
67.
68.
69.
Jeffrey J. Hsu Pryce Gaynor Megan Kamath Ashley Fan Farah Al‐Saffar Daniel Cruz Ali Nsair 《American journal of transplantation》2020,20(7):1911-1915
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is rapidly infecting people worldwide, resulting in the infectious disease coronavirus disease 19 (COVID‐19) that has been declared a pandemic. Much remains unknown about COVID‐19, including its effects on solid organ transplant (SOT) recipients. Given their immunosuppressed state, SOT recipients are presumed to be at high risk of complications with viral infections such as SARS‐CoV‐2. Limited case reports in single SOT recipients, however, have not suggested a particularly severe course in this population. In this report, we present a dual‐organ (heart/kidney) transplant recipient who was found to have COVID‐19 and, despite the presence of a number of risk factors for poor outcomes, had a relatively mild clinical course. 相似文献
70.
Farah Kaissar Leroy Henri-Arthur Karnoub Melodie-Anne Obled Louis Fuentes Stephane Assaker Richard 《European spine journal》2020,29(2):306-313
European Spine Journal - To evaluate whether left hip positioning widened the access corridor using oblique lateral interbody fusion (OLIF) approach during right lateral decubitus (RLD). Ten... 相似文献